Hoda Gabriel - Founder

Hoda Gabriel is a clinical research and development professional with 30 years of experience directing, designing, planning, and successfully executing early and late-phase clinical drug programs within the pharmaceutical industry. Ms. Gabriel is the former VP of Clinical Development at T3D Therapeutics and is currently a consultant. Prior to her current positions, she held director‐level positions with GlaxoSmithKline and Talecris (now Grifols), where she led several international programs and teams to successful NDA/MAA submissions. Additionally, she founded two independent clinical research companies. Ms. Gabriel has experience in the development of multiple therapeutic areas, including CNS, urology, metabolic, cardiovascular, pain, dermatology, and peripheral arterial disease.